NuCana is trading at $1.04, up +5.55%, amid broader market strength, though no direct cause is confirmed.
- Shares closed at $0.99 on October 23.
- No fresh company-specific announcement explaining the October 26 move was identified; NuCanaβs European patent news dates to September 30.
- U.S. stock futures rose as oil eased, ahead of a busy earnings week and the Federal Reserve decision. This is market context, not a confirmed direct cause.